+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Cancer Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Product (Cytotoxic Chemotherapies, Monoclonal Antibodies , Immuno-Oncology Checkpoint Inhibitors, Antibody-Drug Conjugates , Cell and Gene Therapies, Targeted Small Molecule Drugs, Hormonal Therapies), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Hematologic Malignancies , Pancreatic and Gastric Cancers, Ovarian and Cervical Cancers), By Form (Injectable Formulations, Solid Oral Dosages, Liquid Oral Formulations), By End-User (Hospitals and Comprehensive Cancer Networks, Specialized Outpatient Oncology Clinics, Ambulatory Infusion Centers, Academic and Clinical Research Centers), By Distribution Channel (Hospital-Affiliated Pharmacies, Specialty Drug Distributors, Retail and Local Pharmacies, E-Commerce) Companies, and Country Forecast, 2021 to 2034

Global Cancer Treatment Market size is forecast to increase from $282.01 Billion in 2026 to $626.85 Billion in 2034 at a CAGR of 10.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006157
Pages: 210 Pages

Cancer Treatment Facilities Market Size, Share and Growth Outlook, 2026: Analysis By Facility (Multi-Specialty Hospitals, Standalone Cancer Centers , Ambulatory Surgical Centers , Academic and Research Medical Centers), By Core Treatment Offering (Cancer Surgery Facilities, Radiation Therapy Centers, Chemotherapy and Infusion Centers, Immunotherapy Clinics, Bone Marrow Transplantation Units, Hormone Therapy Facilities), By Patient Capacity (Large-Scale , Medium-Scale , Small-Scale ), By Cancer Type Specialization (Solid Tumor Specialist Facilities, Hematological Malignancies Specialist Facilities) Companies, and Country Forecast, 2021 to 2034

Global Cancer Treatment Facilities Market size is forecast to increase from $58.47 Billion in 2026 to $109.84 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006156
Pages: 220 Pages

Cancer Therapeutics and Biotherapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy , Hormone Therapy, Radiation Therapy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood , Cervical and Ovarian Cancer, Head and Neck Cancer), By Route of Administration (Oral , Injectable ), By End-User (Hospitals and Specialty Clinics, Cancer Research Laboratories, Academic Medical Institutes), By Distribution Channel (Hospital Pharmacies, Specialty Drug Stores, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Cancer Therapeutics and Biotherapeutics Market size is forecast to increase from $318.03 Billion in 2026 to $701.81 Billion in 2034 at a CAGR of 10.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006155
Pages: 228 Pages

Cancer Supportive Care Market Size, Share and Growth Outlook, 2026: Analysis By Offering Category (Pharmaceutical Products , Medical Devices, Digital Health and Symptom Monitoring Apps, Support Services), By Application Area (Bone Metastasis and Osteopenia, Chemotherapy-Induced Toxicity , Gastrointestinal Toxicity , Oncology Pain Management, Radiation-Induced Side Effects), By Cancer Type Focus (Solid Tumors, Hematological Malignancies), By End-User (Hospitals and Inpatient Oncology Wards, Specialized Cancer Treatment Clinics and Infusion Centers, Ambulatory Surgical Centers , Hospice and Home Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Cancer Supportive Care Market size is forecast to increase from $28.76 Billion in 2026 to $34.77 Billion in 2034 at a CAGR of 2.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006154
Pages: 216 Pages

Cancer Stem Cells Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Cell-Culturing Products, Cell-Separation Products, Cell Analysis Products, Molecular Analysis Products, Other Supporting Reagents and Assay Kits), By Stem Cell Source (Bone Marrow-Derived, Peripheral Blood-Derived, Umbilical Cord, Induced Pluripotent Stem Cells , Adipose Tissue-Derived), By Mode of Action Focus (Targeted Cancerous Stem Cell Therapies, Immunotherapy-Based Approaches, Chemotherapy Resistance Reversal Agents), By Type of Cancer (Breast Cancer, Blood , Lung Cancer, Brain Cancer, Colorectal Cancer, Pancreatic, Bladder, and Liver Cancers), By End-User (Hospitals and Comprehensive Cancer Centers, Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Cancer Stem Cells Market size is forecast to increase from $3.51 Billion in 2026 to $7.2 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006153
Pages: 217 Pages

Cancer Stem Cell Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Cancer Type (Breast Cancer, Blood Cancer, Lung Cancer, Brain Cancer, Colorectal Cancer, Pancreatic Cancer, Bladder Cancer, Liver Cancer, Other Cancer Types), By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Stem Cell Transplantation, Others), By Stem-Cell Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Induced Pluripotent Stem Cells , Others), By Application (Autologous Stem-Cell Transplant, Allogeneic Stem-Cell Transplant), By Biomarker Type (CD44, CD133, ALDH1, Others), By End-User (Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Cancer Stem Cell Therapeutics Market size is forecast to increase from $3.5 Billion in 2026 to $7.23 Billion in 2034 at a CAGR of 9.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006152
Pages: 227 Pages

Cancer Registry Software Market Size, Share and Growth Outlook, 2026: Analysis By Software Type (Standalone Software, Integrated Software), By Database (Public Data, Commercial Data), By Deployment Model (Cloud-based, On-premises), By Functionality (Data Collection and Management, Reporting and Compliance, Analytics and Visualization, Patient Tracking, Others), By End-User (Hospitals and Medical Practices, Government Organizations, Research Centers, Pharmaceutical and Biotechnology Companies, Private Players) Companies, and Country Forecast, 2021 to 2034

Global Cancer Registry Software Market size is forecast to increase from $112.8 Million in 2026 to $243.56 Million in 2034 at a CAGR of 10.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006151
Pages: 229 Pages

Cancer Profiling Market Size, Share and Growth Outlook, 2026: Analysis By Product and Services (Instruments, Consumables, Services, Software and Bioinformatics), By Technology (Immunoassays, Next-Generation Sequencing , Polymerase Chain Reaction , In-situ Hybridization , Microarrays, Mass Spectrometry, Other Technologies), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Metabolic Biomarkers, Circulating Tumor Cells , Exosomal and cfDNA Biomarkers, Other Biomarker Types), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types), By Application (Diagnostics, Prognosis and Risk Assessment, Treatment Selection and Monitoring, Research Applications, Screening and Early Detection), By End-User (Hospitals and Reference Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Cancer Profiling Market size is forecast to increase from $14.76 Billion in 2026 to $32.34 Billion in 2034 at a CAGR of 10.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006150
Pages: 223 Pages

Cancer Pain Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Opioids , Non-Opioids , Adjuvant Analgesics , Targeted Pain Therapies , Medical Cannabinoids), By Route of Administration (Oral , Parenteral , Transdermal , Sublingual & Buccal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Cancer Pain Therapeutics Market size is forecast to increase from $7.61 Billion in 2026 to $11.95 Billion in 2034 at a CAGR of 5.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006149
Pages: 228 Pages

Cancer Pain Management Market Size, Share and Growth Outlook, 2026: Analysis By Indication (Lung Cancer-Related Pain, Breast Cancer-Related Pain, Colorectal Cancer-Related Pain, Prostate Cancer-Related Pain, Blood Cancer-Related Pain), By Pathophysiology (Bone Metastasis Pain, Neuropathic Pain, Visceral Pain, Somatic Pain), By End-User (Inpatient Settings , Outpatient Clinics, Homecare & Palliative Care Centers, Specialty Pain Clinics) Companies, and Country Forecast, 2021 to 2034

Global Cancer Pain Management Market size is forecast to increase from $8.7 Billion in 2026 to $14.66 Billion in 2034 at a CAGR of 6.74% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006148
Pages: 215 Pages